Molbio Diagnostics has updated its Corporate Identification Number following its public listing, officially transitioning its status on the corporate portal from unlisted to listed. This milestone reflects the completion of its exchange debut and marks a key operational shift for retail investors tracking its public market journey.
Molbio Diagnostics Limited has made the audio recording of its earnings call for the quarter ended June 30, 2026, available on its official website. Investors can access the recording on www.molbiodiagnostics.com to review the discussion on the standalone and consolidated financial results.
Molbio Diagnostics Limited has informed the Exchange about Investor Presentation on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026
Molbio Diagnostics Limited has informed the Exchange about Copy of Newspaper Publication of Un-audited Financial Results for the quarter ended June 30, 2026.
Molbio Diagnostics Limited has informed the Exchange regarding a press release dated September 07, 2026, titled "Press Release for the Quarter ended June 30, 2026.".
